Wellness Device Firms Should Follow Regulatory Prompts, Expert Says
This article was originally published in The Gray Sheet
Executive Summary
Many wearable consumer health products entering the market don't fall within the bounds of FDA regulation, but that does not mean companies selling the products should ignore recommendations coming out of the agency, according to Vernessa Pollard, a partner with McDermott, Will & Emery, who spent six years at FDA's Office of Chief Counsel. Maintaining validation according to FDA rules and guidelines makes "good business sense," she said in an interview.
You may also be interested in...
Top FDAer Skeptical Of Wearable Devices, Says Agency Is Working To Improve Standards And Technology
Amy Abernethy, the principal deputy commissioner at the US FDA, told attendees at a 25 July medical conference that she's somewhat skeptical about using wearable technologies for clinical needs because they still haven’t proven their accuracy. However, she says the device center is working hard to develop new standards for such products and is looking for funding to develop them.
ONC Outlines Plan To Expand Telehealth, Mobile Health
The agency released its five-year strategic plan to encourage broader adoption of health IT, including telehealth and mobile health technologies.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.